Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06267859
Other study ID # No. 2 of 2023/11/7
Secondary ID
Status Recruiting
Phase Early Phase 1
First received
Last updated
Start date November 8, 2023
Est. completion date January 30, 2034

Study information

Verified date February 2024
Source Tashkent Pediatric Medical Institute
Contact Shokhida T Turdieva, DSc
Phone +998935872570
Email Shohidahon69@mail.ru
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of the clinical study is to clarify the course of common congenital, infectious, and non-infectious diseases in children living in Uzbekistan, and to develop methods for their treatment and rehabilitation. The main questions it aims to answer: - Analysis of common congenital diseases among children; - Analysis of commonly diagnosed bronchopulmonary and cardiovascular diseases among children; - Based on the results of the primary research, common diseases among children will be identified; - Analysis of existing treatment methods and their effectiveness; - Development of modern methods of treatment and rehabilitation of children.


Description:

Children's health is a priority in modern medicine. Some childhood diseases are most often encountered in the practice of pediatricians and family doctors. Children with these diseases need early diagnosis, treatment, and rehabilitation. Patient selection criteria are: - children from birth to 15 years; - children permanently residing in the territory where the clinical examination is carried out; - children included in the group of "frequently ill children"; - patients without severe chronic diseases. Exclusion criteria: - Teenagers over 15 years old; - Patients with severe neurological and mental diseases; - Patients with endocrinological diseases; - Patients with long-term chronic somatic diseases; - Children without genetic pathologies. Clinical research methods: - Collection of anamnestic data; - General examination of patients (auscultation, palpation, percussion); - If necessary: consultation with a geneticist and pediatric doctors of various specialties (cardiologist, surgeon, urologist, nephrologist, otolaryngologist, pulmonologist, immunologist, allergist) - Standard laboratory tests (general analysis of blood, urine, feces); - Standard biochemical studies (microelements of blood and enzymes in venous blood); - Instrumental studies: chest X-ray, ultrasound examination of internal organs (chest and abdominal organs), computed tomography (chest and abdominal organs); - Study of immunological status (cellular immunity, according to standard methods); Immunological research methods - flow cytometry, mIU/mL: immunogram - CD3, CD3/4, CD3/8, CD19, CD16/56, CD3/16/56, CD3/HLA-; and others; - Study of antioxidant status (TAS, using the PSR method, mmol/L); - Assessing the quality of life of patients (methods: PedsQLtm 4.0; HBSC, indicator: total score on the screening survey).


Recruitment information / eligibility

Status Recruiting
Enrollment 110
Est. completion date January 30, 2034
Est. primary completion date December 30, 2033
Accepts healthy volunteers No
Gender All
Age group 3 Days to 15 Years
Eligibility Inclusion Criteria: - children from birth to 15 years; - children permanently residing in the territory where the clinical examination is carried out; - children included in the group of "frequently ill children"; - patients without severe chronic diseases. Exclusion Criteria: - Teenagers over 15 years old; - Patients with severe neurological and mental diseases; - Patients with endocrinological diseases; - Patients with long-term chronic somatic diseases; - Children without genetic pathologies.

Study Design


Intervention

Combination Product:
The use of a combination of microelements and vitamins against the background of physiotherapy
If necessary, necessary microelements and vitamins will be added to the treatment process. At the same time, physiotherapeutic procedures will be added at the rehabilitation stage.

Locations

Country Name City State
Uzbekistan Turdieva Shokhida Tolkunovna Tashkent Yunus-obad District

Sponsors (1)

Lead Sponsor Collaborator
Tashkent Pediatric Medical Institute

Country where clinical trial is conducted

Uzbekistan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Working with archival documentation. Medical and statistical analysis of data from children's medical institutions is carried out to identify common somatic diseases in children from birth to 15 years old associated with impaired immunity.
Evaluation criterion:
medical archival documentation of children's clinics in the region;
statistical analysis of archival documentation on the morbidity of children (acute respiratory: acute bronchitis and acute pneumonia; cardiovascular diseases: congenital heart disease, congenital and acquired carditis).
one year
Primary Formation of a group of patients to study immunity and the antioxidant system in venous blood. Objective: Preparations for a clinical trial are underway.
Work in progress:
400 children with diseases of the bronchopulmonary system and congenital heart defects will be selected;
preparation and submission to the Ethics Committee under the Ministry of Health of Uzbekistan of all necessary documentation for the planned clinical trial among children;
Evaluation criterion:
- The percentage of detection of acute bronchopulmonary and congenital heart defects in the region of residence (results of medical statistics).
one year
Primary Clinical scientific research. A clinical study of sick children (acute respiratory: acute bronchitis and acute pneumonia; cardiovascular diseases: congenital heart disease, congenital and acquired carditis) is being conducted to determine the presence of immunological and antioxidant blood parameters.
Work in progress:
Screening medical examination of children (objective examination, general blood test - ELISA method);
Examination of venous blood for indicators of immune status (extended immunogram: CD3, CD3/4, CD3/8, CD19, and others), method: flow cytometry of venous blood, mIU/mL;
the study of antioxidant status in sick children (Total antioxidant status, method: venous blood PCR, mmol/L);
publication of the research results.
Evaluation criterion:
opinion of reviewers and experts in this field (comparison of the results obtained by other scientists - immunological and antioxidant research)
changes in immune and antioxidant status indicators in sick children to healthy peers.
five years.
Primary Clinical trial evaluation. The development and implementation of clinical recommendations for practicing pediatricians, pediatric pulmonologists, and cardiologists on improving children's health with acute respiratory (acute bronchitis, pneumonia) and cardiovascular (CHD, congenital and acquired carditis) diseases.
Work in progress:
development and implementation of clinical recommendations for pediatricians, pediatric pulmonologists, and cardiologists;
assessment of the effectiveness of clinical recommendations based on repeated laboratory tests (immunological (flow cytometry, mIU/mL) and TAS (PCR, mmol/L)), after six months of implementation of the recommendations.
Evaluation criterion:
opinion of reviewers and experts - review;
assessing the quality of life of patients (methods: PedsQLtm 4.0; HBSC), indicator: total score on the screening survey;
number of recurrent illnesses and complications, indicator: the number of patients as a percentage.
three years
See also
  Status Clinical Trial Phase
Completed NCT01671566 - Interval Training in Adults With Congenital Heart Disease a Randomized Trial N/A
Recruiting NCT01421030 - Outcomes in Patients and Their Closest Relatives Treated for Congenital Heart Disease With Catheter Based or Surgical Techniques Phase 0
Completed NCT01567579 - An Evaluation of Routine Developmental Follow-Up in Infants and Children With Congenital Heart Disease
Withdrawn NCT00981591 - Inhaled Iloprost as an Adjunct to Inhaled Nitric Oxide in Pediatric Critical Care Patients Phase 1/Phase 2
Terminated NCT00208676 - Using Tissue Doppler/Synchronization to Determine Heart Function in Children With Congenital Heart Disease N/A
Completed NCT01941576 - Effects of rhBNP in Pediatrics After Corrective Repair of Tetralogy Of Fallot N/A
Completed NCT01475357 - Intestinal Function in Neonates With Complex Congenital Heart Disease N/A
Active, not recruiting NCT01227096 - Randomized Controlled Trial of the Effects of Electroacupuncture Preconditioning in Children Undergoing Cardiac Surgery N/A
Completed NCT00397514 - Assessing the Hemodynamic Benefits of Cardiac Resynchronization Therapy in Children Following Open-Heart Surgery N/A
Completed NCT01201486 - Use of Color Doppler in Routine Examination of Fetal Heart in Second Trimester N/A
Completed NCT02232399 - Is Levosimendan Superior to Milrinone Regarding Acute Kidney Injury After Cardiac Surgery for Congenital Heart Disease? Phase 2
Completed NCT05191654 - Investigation of Cardiopulmonary Parameters, Motor Development and Muscle Strength in DS With and Without CHD
Completed NCT02320669 - Phase 3 Triiodothyronine Supplementation for Infants After Cardiopulmonary Bypass Phase 3
Completed NCT01489475 - Plasma Angiopoietin Levels in Children Following Cardiopulmonary Bypass N/A
Withdrawn NCT00579358 - Molecular Basis of Congenital Heart Defects
Recruiting NCT01196182 - Congenital Heart Disease GEnetic NEtwork Study (CHD GENES)
Recruiting NCT03822442 - MRI to Predict Rejection and Failure in Transplant and Cardiomyopathy Patients
Recruiting NCT04382573 - Better Delineation of CDK13 Related Phenotype and Epigenetic Signature.
Completed NCT00450684 - Cardiac Resynchronization Therapy in Congenital Heart Defects Phase 2/Phase 3
Terminated NCT00208754 - Heart Failure in Adult Patients With a History of Congenital Heart Disease N/A